2013 Q4 Form 10-K Financial Statement

#000119312514089394 Filed on March 07, 2014

View on sec.gov

Income Statement

Concept 2013 Q4 2013 2012 Q4
Revenue $9.232M $39.66M $10.53M
YoY Change -12.31% 7.8% 6.39%
Cost Of Revenue $4.939M $22.60M $5.117M
YoY Change -3.48% 9.63% -17.55%
Gross Profit $4.293M $17.06M $5.411M
YoY Change -20.66% 6.07% 46.64%
Gross Profit Margin 46.5% 43.01% 51.4%
Selling, General & Admin $7.430M $29.97M $6.794M
YoY Change 9.36% 16.75% 14.42%
% of Gross Profit 173.07% 175.7% 125.56%
Research & Development $4.618M $15.19M $2.164M
YoY Change 113.4% 99.75% 38.54%
% of Gross Profit 107.57% 89.05% 39.99%
Depreciation & Amortization $340.0K $745.0K $160.0K
YoY Change 112.5% 0.13% -27.27%
% of Gross Profit 7.92% 4.37% 2.96%
Operating Expenses $12.10M $45.35M $9.009M
YoY Change 34.3% 35.51% 19.32%
Operating Profit -$7.806M -$28.30M -$3.598M
YoY Change 116.95% 63.58% 7.95%
Interest Expense $1.800M $332.0K $2.130M
YoY Change -15.49% -39.75%
% of Operating Profit
Other Income/Expense, Net $1.999M -$14.82M $1.993M
YoY Change 0.3% -1012.0% -145.78%
Pretax Income -$5.807M -$43.12M -$1.605M
YoY Change 261.81% 163.56% -79.12%
Income Tax $53.00K $218.0K $111.0K
% Of Pretax Income
Net Earnings -$5.860M -$43.34M -$1.716M
YoY Change 241.49% 172.27% -77.82%
Net Earnings / Revenue -63.47% -109.28% -16.3%
Basic Earnings Per Share -$0.08 -$0.64 -$0.03
Diluted Earnings Per Share -$0.10 -$0.64 -$0.07
COMMON SHARES
Basic Shares Outstanding 70.46M shares 67.57M shares
Diluted Shares Outstanding 67.57M shares

Balance Sheet

Concept 2013 Q4 2013 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $57.70M $57.70M $26.70M
YoY Change 116.1% 116.1% 3.49%
Cash & Equivalents $29.49M $29.50M $26.70M
Short-Term Investments $28.20M $28.20M $0.00
Other Short-Term Assets $442.0K $1.200M $2.038M
YoY Change -78.31% -53.85% 236.86%
Inventory $13.06M $13.10M $10.18M
Prepaid Expenses $848.0K $638.0K
Receivables $6.125M $6.100M $4.444M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $78.15M $78.20M $44.00M
YoY Change 77.64% 77.73% 10.71%
LONG-TERM ASSETS
Property, Plant & Equipment $2.189M $2.200M $1.698M
YoY Change 28.92% 29.41% -16.44%
Goodwill $1.316M $1.316M
YoY Change 0.0% 0.0%
Intangibles $1.344M $1.546M
YoY Change -13.07% -11.56%
Long-Term Investments
YoY Change
Other Assets $70.00K $400.0K $59.00K
YoY Change 18.64% 0.0% -74.24%
Total Long-Term Assets $5.227M $5.200M $4.923M
YoY Change 6.18% 6.12% -12.53%
TOTAL ASSETS
Total Short-Term Assets $78.15M $78.20M $44.00M
Total Long-Term Assets $5.227M $5.200M $4.923M
Total Assets $83.38M $83.40M $48.92M
YoY Change 70.45% 70.55% 7.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.674M $5.700M $7.186M
YoY Change -21.04% -20.83% 53.55%
Accrued Expenses $9.813M $9.800M $7.619M
YoY Change 28.8% 28.95% 30.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.400M $3.400M $4.800M
YoY Change -29.17% -29.17% 92.0%
Total Short-Term Liabilities $39.42M $39.40M $25.61M
YoY Change 53.92% 53.91% 21.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $2.900M
YoY Change -100.0% -100.0% -38.3%
Other Long-Term Liabilities $1.073M $1.100M $1.241M
YoY Change -13.54% -8.33% -0.16%
Total Long-Term Liabilities $1.073M $1.100M $1.241M
YoY Change -13.54% -73.17% -0.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $39.42M $39.40M $25.61M
Total Long-Term Liabilities $1.073M $1.100M $1.241M
Total Liabilities $40.59M $40.60M $29.81M
YoY Change 36.14% 36.24% 10.19%
SHAREHOLDERS EQUITY
Retained Earnings -$503.2M -$459.9M
YoY Change 9.42% 3.59%
Common Stock $546.0M $56.00K
YoY Change 974858.93% 9.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $42.80M $42.80M $19.11M
YoY Change
Total Liabilities & Shareholders Equity $83.38M $83.40M $48.92M
YoY Change 70.45% 70.55% 7.83%

Cashflow Statement

Concept 2013 Q4 2013 2012 Q4
OPERATING ACTIVITIES
Net Income -$5.860M -$43.34M -$1.716M
YoY Change 241.49% 172.27% -77.82%
Depreciation, Depletion And Amortization $340.0K $745.0K $160.0K
YoY Change 112.5% 0.13% -27.27%
Cash From Operating Activities -$6.530M -$26.80M -$2.880M
YoY Change 126.74% 92.55% 166.67%
INVESTING ACTIVITIES
Capital Expenditures -$220.0K $663.0K $20.00K
YoY Change -1200.0% 718.52% -150.0%
Acquisitions
YoY Change
Other Investing Activities $650.0K $15.00K $0.00
YoY Change 1400.0% -100.0%
Cash From Investing Activities $430.0K -$29.06M $20.00K
YoY Change 2050.0% -14274.15% -92.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $61.43M
YoY Change 331.78%
Debt Paid & Issued, Net $7.568M
YoY Change 419.42%
Cash From Financing Activities 11.23M 58.64M 2.890M
YoY Change 288.58% 293.29% -74.98%
NET CHANGE
Cash From Operating Activities -6.530M -26.80M -2.880M
Cash From Investing Activities 430.0K -29.06M 20.00K
Cash From Financing Activities 11.23M 58.64M 2.890M
Net Change In Cash 5.130M 2.789M 30.00K
YoY Change 17000.0% 132.61% -99.72%
FREE CASH FLOW
Cash From Operating Activities -$6.530M -$26.80M -$2.880M
Capital Expenditures -$220.0K $663.0K $20.00K
Free Cash Flow -$6.310M -$27.46M -$2.900M
YoY Change 117.59% 96.17% 178.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2010Q3 us-gaap Goodwill
Goodwill
1316000
CY2010Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
2017000
CY2010Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
270000
CY2010Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
3738000
CY2010Q3 cers Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets
135000
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
72149000 shares
CY2013Q2 dei Entity Public Float
EntityPublicFloat
257300000
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.42
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7007000 shares
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
23732000
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28948000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.70
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7362000 shares
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-459852000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
77000
CY2012Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
62000
CY2011Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
7979000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
18313000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25497000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56252000 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.40
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8504000 shares
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
112500000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56252000 shares
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
2896000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
25613000
CY2012Q4 us-gaap Secured Debt
SecuredDebt
7724000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2692000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8322000
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2575000
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
478903000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7186000
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
190500000
CY2012Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
5903000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1241000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
19107000
CY2012Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
5903000
CY2012Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
4828000
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7619000
CY2012Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
7773000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2012Q4 us-gaap Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
5903000
CY2012Q4 us-gaap Liabilities
Liabilities
29812000
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
471000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
56000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48919000
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
62000
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
300000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
59000
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
638000
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
137700000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
4800000
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
190500000
CY2012Q4 us-gaap Goodwill
Goodwill
1316000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4444000
CY2012Q4 us-gaap Inventory Net
InventoryNet
10180000
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
10268000
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
10268000
CY2012Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
5598000
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
304000
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1546000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
200000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
100000
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10020000
CY2012Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1594000
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6629000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
700000
CY2012Q4 cers Deferred Tax Assets Acquisition Related Costs
DeferredTaxAssetsAcquisitionRelatedCosts
200000
CY2012Q4 cers Debt Instrument Unamortized Current
DebtInstrumentUnamortizedCurrent
29000
CY2012Q4 cers Accrued Inventory
AccruedInventory
2352000
CY2012Q4 cers Cumulative Outstanding Trade Receivables Number Of Major Customers
CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers
3 Customer
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
10268000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
43996000
CY2012Q4 cers Debt Instrument Carrying Current
DebtInstrumentCarryingCurrent
4857000
CY2012Q4 cers Deferred Tax Liabilities Amortization Of Intangible Assets
DeferredTaxLiabilitiesAmortizationOfIntangibleAssets
62000
CY2012Q4 cers Inventory Write Down Against Which Offsetting Warranty Claim Available
InventoryWriteDownAgainstWhichOffsettingWarrantyClaimAvailable
1700000
CY2012Q4 cers Debt Instrument Carrying Non Current
DebtInstrumentCarryingNonCurrent
2916000
CY2012Q4 cers Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
1300000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.46
CY2012Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
900000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1698000
CY2012Q4 us-gaap Assets
Assets
48919000
CY2012Q4 us-gaap Noncurrent Assets
NoncurrentAssets
3244000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26696000
CY2012Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
644000
CY2012Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
3900000
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
30800000
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1546000
CY2012Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
1062000
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2038000
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3551000
CY2012Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
24000
CY2012Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
55000
CY2012Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10268000
CY2012Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
10268000
CY2012Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
49000
CY2012Q4 us-gaap Inventory Finished Goods And Work In Process Net Of Reserves
InventoryFinishedGoodsAndWorkInProcessNetOfReserves
10180000
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2017000
CY2012Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
100000
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
10268000
CY2012Q4 cers Debt Instrument Unamortized Noncurrent
DebtInstrumentUnamortizedNoncurrent
20000
CY2012Q4 cers Computer Equipment Gross
ComputerEquipmentGross
550000
CY2012Q4 cers Deferred Tax Assets Capitalized Research And Development Costs
DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
9100000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71859000 shares
CY2013Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
18600000 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6589000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10405000 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.45
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.43
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
112500000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
10028000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71859000 shares
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1147000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
39424000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
7000
CY2013Q4 us-gaap Secured Debt
SecuredDebt
3366000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2527000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8584000
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3733000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
545905000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1919000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5674000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
68000
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
199000000
CY2013Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
20390000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1073000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
42795000
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3500000
CY2013Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
20390000
CY2013Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
3366000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-503189000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
181000
CY2013Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
89000
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9813000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
553000
CY2013Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3366000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2013Q4 us-gaap Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
20390000
CY2013Q4 us-gaap Liabilities
Liabilities
40586000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
142000
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
673000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
72000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
83381000
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
89000
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
400000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
70000
CY2013Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
28191000
CY2013Q4 us-gaap Noncurrent Assets
NoncurrentAssets
3533000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29485000
CY2013Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
763000
CY2013Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
3900000
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
32100000
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1344000
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
21555000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
32724000
CY2013Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
1083000
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
442000
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4863000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
200000
CY2013Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
100000
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
848000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
142500000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
200000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
4900000
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
199000000
CY2013Q4 us-gaap Goodwill
Goodwill
1316000
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
36834000
CY2013Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
30700000
CY2013Q4 us-gaap Cost Method Investments
CostMethodInvestments
0
CY2013Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
5628000
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
308000
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1344000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
100000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
200000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6125000
CY2013Q4 us-gaap Inventory Net
InventoryNet
13063000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
200000
CY2013Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
6140000
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8200000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
100000
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10773000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
200000
CY2013Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1751000
CY2013Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
800000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2189000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
200000
CY2013Q4 us-gaap Assets
Assets
83381000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
31730000
CY2013Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
155000
CY2013Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
36841000
CY2013Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
6134000
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
36841000
CY2013Q4 us-gaap Inventory Finished Goods And Work In Process Net Of Reserves
InventoryFinishedGoodsAndWorkInProcessNetOfReserves
13063000
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2017000
CY2013Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
100000
CY2013Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
30701000
CY2013Q4 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
36834000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
78154000
CY2013Q4 cers Long Term Purchase Commitment Amount Due Within One Year
LongTermPurchaseCommitmentAmountDueWithinOneYear
3400000
CY2013Q4 cers Debt Instrument Carrying Current
DebtInstrumentCarryingCurrent
3366000
CY2013Q4 cers Finite Lived Intangible Assets Amortization Expense Year Six
FiniteLivedIntangibleAssetsAmortizationExpenseYearSix
200000
CY2013Q4 cers Deferred Tax Liabilities Amortization Of Intangible Assets
DeferredTaxLiabilitiesAmortizationOfIntangibleAssets
89000
CY2013Q4 cers Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
1300000
CY2013Q4 cers Deferred Tax Assets Acquisition Related Costs
DeferredTaxAssetsAcquisitionRelatedCosts
200000
CY2013Q4 cers Leasehold Improvement Reflected In Other Non Current Liabilities
LeaseholdImprovementReflectedInOtherNonCurrentLiabilities
600000
CY2013Q4 cers Accrued Inventory
AccruedInventory
3553000
CY2013Q4 cers Long Term Purchase Commitment Amount Due Within Two Years
LongTermPurchaseCommitmentAmountDueWithinTwoYears
1300000
CY2013Q4 cers Leasehold Improvement Reflected In Accrued Liabilities
LeaseholdImprovementReflectedInAccruedLiabilities
100000
CY2013Q4 cers Outstanding Liability Related To Leasehold Improvements Current And Non Current
OutstandingLiabilityRelatedToLeaseholdImprovementsCurrentAndNonCurrent
700000
CY2013Q4 cers Cumulative Outstanding Trade Receivables Number Of Major Customers
CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers
2 Customer
CY2013Q4 cers Options And Other Stock Based Awards
OptionsAndOtherStockBasedAwards
10500000 shares
CY2013Q4 cers Long Term Purchase Commitment Amount Due Within Three Years
LongTermPurchaseCommitmentAmountDueWithinThreeYears
1300000
CY2013Q4 cers Computer Equipment Gross
ComputerEquipmentGross
651000
CY2013Q4 cers Deferred Tax Assets Capitalized Research And Development Costs
DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
12300000
CY2013Q4 cers Finite Lived Intangible Assets Amortization Expense Year Seven
FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven
100000
CY2013Q4 cers Available For Sale Securities Gross Unrealized Gain Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainLossAccumulatedInInvestments
7000
CY2013Q4 cers Operating Leases Future Minimum Payments Due In Five And Thereafter Years
OperatingLeasesFutureMinimumPaymentsDueInFiveAndThereafterYears
9000
CY2013Q4 cers Prior Written Notice Period For Termination Of Agreement
PriorWrittenNoticePeriodForTerminationOfAgreement
P24M
CY2010 cers Proceeds From Landlord Financing Leasehold Improvement
ProceedsFromLandlordFinancingLeaseholdImprovement
1100000
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.45
CY2011 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
11.52
CY2011 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1237000 shares
CY2011 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48050000 shares
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.36
CY2011 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
2000000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.37
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15632000
CY2011 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
112000 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
465000 shares
CY2011 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13595000 shares
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.81
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2169000 shares
CY2011 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48050000 shares
CY2011 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9678000
CY2011 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-108000
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-17461000
CY2011 us-gaap Income Taxes Paid
IncomeTaxesPaid
125000
CY2011 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
13000
CY2011 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-55000
CY2011 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
30602000
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
622000
CY2011 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
92000
CY2011 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-16982000
CY2011 us-gaap Interest Paid
InterestPaid
1024000
CY2011 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
420000
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-16839000
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1304000
CY2011 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-529000
CY2011 us-gaap Revenues
Revenues
33044000
CY2011 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
5008000
CY2011 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17090000
CY2011 us-gaap Gross Profit
GrossProfit
12067000
CY2011 us-gaap Revenue From Grants
RevenueFromGrants
2442000
CY2011 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5000
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-15924000
CY2011 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
158000
CY2011 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
0
CY2011 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-915000
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-16982000
CY2011 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
601000
CY2011 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-108000
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1850000
CY2011 us-gaap Cost Of Goods Sold
CostOfGoodsSold
18535000
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11618000
CY2011 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
700000
CY2011 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4158000
CY2011 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
4910000
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
1850000
CY2011 us-gaap Depreciation And Amortization
DepreciationAndAmortization
600000
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3451000
CY2011 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
83000
CY2011 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2011 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
666000
CY2011 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2011 us-gaap Operating Expenses
OperatingExpenses
30433000
CY2013 dei Entity Registrant Name
EntityRegistrantName
CERUS CORP
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2011 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
4000
CY2011 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23053000
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
143000
CY2011 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-137000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
200000
CY2011 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-336000
CY2011 us-gaap Interest Expense
InterestExpense
964000
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1450000
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9273000
CY2011 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-5725000
CY2011 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
7178000
CY2011 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2011 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
2300000
CY2011 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
922000
CY2011 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
202000
CY2011 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
143000
CY2011 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
143000
CY2011 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1850000
CY2011 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
CY2011 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-68000
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
563000
CY2011 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2011 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2011 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
143000
CY2011 cers Warrant Liability Revaluation Gain Loss
WarrantLiabilityRevaluationGainLoss
486000
CY2011 cers Income Tax Reconciliation Nondeductible Expense Lobbying Expenses
IncomeTaxReconciliationNondeductibleExpenseLobbyingExpenses
112000
CY2011 cers Payment For Royalty
PaymentForRoyalty
2200000
CY2011 cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
9600000
CY2011 cers Income Tax Reconciliation Change In Fair Value Of Warrants
IncomeTaxReconciliationChangeInFairValueOfWarrants
-165000
CY2011 cers Income Tax Reconciliation Expiration Of Federal Net Operating Losses
IncomeTaxReconciliationExpirationOfFederalNetOperatingLosses
-1744000
CY2011 cers Purchase Commitment Payments
PurchaseCommitmentPayments
3600000
CY2011 cers Issuance Of Common Stock From Exercise Of Stock Options Or Warrants And Purchases From Employee Stock Purchase Plans Value
IssuanceOfCommonStockFromExerciseOfStockOptionsOrWarrantsAndPurchasesFromEmployeeStockPurchasePlansValue
143000
CY2013 dei Trading Symbol
TradingSymbol
CERS
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0001020214
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.13
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.64
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y4M2D
CY2013 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.60 pure
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
6.71
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.64
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
189000 shares
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67569000 shares
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.82
CY2013 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
8500000
CY2013 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P10Y
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.03
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16370000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26797000
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y3M
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
297000 shares
CY2013 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 18px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Concentration of Credit Risk</b></font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of investments and accounts receivable.</font></p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Pursuant to the Company&#x2019;s investment policy, substantially all of the Company&#x2019;s investments are maintained at a major financial institution in the United States of high credit standing, which at times, may exceed federally insured limits. The Company has not experienced any losses in its investments and believes it is not exposed to any significant risk.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Concentrations of credit risk with respect to trade receivables exist. However, in connection with the Company&#x2019;s revolving line of credit, as discussed in Note 11 in the Notes to Consolidated Financial Statements, the Company purchased a credit insurance policy that mitigates some of its credit risk, as the policy will pay either the Company or its lender on eligible claims filed on its outstanding receivables. On a regular basis, including at the time of sale, the Company performs credit evaluations of its customers. Generally, the Company does not require collateral from its customers to secure accounts receivable. To the extent that the Company determines specific invoices or customer accounts may be uncollectible, the Company establishes an allowance for doubtful accounts against the accounts receivable on its consolidated balance sheets and records a charge on its consolidated statements of operations as a component of selling, general and administrative expenses.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company had two customers and three customers that accounted for more than 10% of the Company&#x2019;s outstanding trade receivables at December&#xA0;31, 2013 and 2012, respectively. These customers cumulatively represented approximately 48% and 59% of the Company&#x2019;s outstanding trade receivables at December&#xA0;31, 2013 and 2012, respectively. To date, the Company has not experienced collection difficulties from these customers.</font></p> </div>
CY2013 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 18px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Reclassifications</b></font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In 2012, certain reclassifications have been made to prior period reported amounts to conform to the current period presentations. Previously the Company had presented its provision for income taxes as a component of other income (expense) , net on the Consolidated Statements of Operations. The Company has reclassified the provision for income taxes to a separate line item in the Consolidated Statements of Operations, and as presented in Note 17. This reclassification had no impact on net loss, total assets or total stockholders&#x2019; equity.</font></p> </div>
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
234000 shares
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2"><b>Use of Estimates</b></font></p> <p style="margin-top:6px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">The preparation of financial statements requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, including those related to revenue recognition, inventory valuation, certain accrued liabilities, valuation and impairment of purchased intangibles and goodwill, valuation of warrants, valuation of stock options under share-based payments, valuation allowance of its deferred tax assets and uncertain income tax positions. The Company basis its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances, the results of which form its basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from those estimates under different assumptions or conditions.</font></p> </div>
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.14
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2621000 shares
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67569000 shares
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y18D
CY2013 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
CY2013 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 18px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Guarantee and Indemnification Arrangements</b></font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company recognizes the fair value for guarantee and indemnification arrangements issued or modified by the Company after December&#xA0;31, 2002. In addition, the Company monitors the conditions that are subject to the guarantees and indemnifications in order to identify if a loss has occurred. If the Company determines it is probable that a loss has occurred, then any such estimable loss would be recognized under those guarantees and indemnifications. Some of the agreements that the Company is a party to contain provisions that indemnify the counter party from damages and costs resulting from claims that the Company&#x2019;s technology infringes the intellectual property rights of a third party or claims that the sale or use of the Company&#x2019;s products have caused personal injury or other damage or loss. The Company has not received any such requests for indemnification under these provisions and has not been required to make material payments pursuant to these provisions.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company generally provides for a one-year warranty on certain of its INTERCEPT blood-safety products covering defects in materials and workmanship. The Company accrues costs associated with warranty obligations when claims become known and are estimable. During the year ended December&#xA0;31, 2012, the Company provided for and settled the claims for warranty obligations of $0.9 million related to replacement costs for certain of its products that the Company identified were defective or had the potential of being defective. Prior to this incident, there have been very few warranty costs incurred. As a result, the Company had not accrued for any potential future warranty costs at December&#xA0;31, 2011. In addition, the Company believes that the defective products and those that had the potential of being defective identified during the year ended December&#xA0;31, 2012 are isolated. Accordingly, the Company has not accrued for any other incremental potential future warranty costs for its products at December&#xA0;31, 2013.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In connection with the warranty obligations provided for in relation to certain of its products during the year ended December&#xA0;31, 2012, the Company filed a warranty claim against Fresenius, which Fresenius accepted. As a result, the Company recorded a current asset of $1.8 million on its consolidated balance sheets as of December&#xA0;31, 2012 representing the full amount of the warranty claim against Fresenius as Fresenius will supply the Company with replacement products or credit notes for those defective or potentially defective products. The Company also wrote-down the value of certain unsalable inventory of $1.7 million related to these products as an offsetting warranty claim against Fresenius. As of December&#xA0;31, 2013 the Company no longer has a warranty claim against Fresenius and all unsalable inventory has been returned to Fresenius.</font></p> </div>
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
15099000
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
61454000
CY2013 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
7000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-44035000
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
146000
CY2013 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-339000
CY2013 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
15000
CY2013 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
39657000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
916000
CY2013 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
2926000
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
266000
CY2013 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-43337000
CY2013 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
30010000
CY2013 us-gaap Interest Paid
InterestPaid
294000
CY2013 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2733000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-43119000
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1681000
CY2013 us-gaap Goodwill Other Changes
GoodwillOtherChanges
0
CY2013 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
533000
CY2013 us-gaap Revenues
Revenues
39657000
CY2013 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
4642000
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-43330000
CY2013 us-gaap Gross Profit
GrossProfit
17055000
CY2013 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0
CY2013 us-gaap Revenue From Grants
RevenueFromGrants
0
CY2013 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
25000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-28299000
CY2013 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
663000
CY2013 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-56000
CY2013 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
0
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14820000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-43337000
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1813000
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3268000
CY2013 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2013 us-gaap Cost Of Goods Sold
CostOfGoodsSold
22602000
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
27000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
58643000
CY2013 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
700000
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
9934000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
3268000
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
400000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2789000
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-10000
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2013 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
1631000
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2013 us-gaap Operating Expenses
OperatingExpenses
45354000
CY2013 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
22000
CY2013 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
29965000
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
218000
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
104000
CY2013 cers Income Tax Reconciliation Change In Fair Value Of Warrants
IncomeTaxReconciliationChangeInFairValueOfWarrants
4926000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
600000
CY2013 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2121000
CY2013 us-gaap Interest Expense
InterestExpense
520000
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense Amortization
IncomeTaxReconciliationNondeductibleExpenseAmortization
21000
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1512000
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
61425000
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-14661000
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
21000
CY2013 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
15187000
CY2013 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
3102000
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
6000
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
557000
CY2013 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
202000
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
191000
CY2013 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
191000
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3268000
CY2013 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
612000
CY2013 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-121000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29057000
CY2013 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2013 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2013 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1684000
CY2013 cers Settlements Of Warranty Claims
SettlementsOfWarrantyClaims
1272000
CY2013 cers Safety Product Warranty Period
SafetyProductWarrantyPeriod
P1Y
CY2013 cers Warrant Liability Revaluation Gain Loss
WarrantLiabilityRevaluationGainLoss
-15099000
CY2013 cers Income Tax Reconciliation Nondeductible Expense Lobbying Expenses
IncomeTaxReconciliationNondeductibleExpenseLobbyingExpenses
107000
CY2013 cers Minimum Term Of Non Cancelable Operating Leases
MinimumTermOfNonCancelableOperatingLeases
P1Y
CY2013 cers Payment For Royalty
PaymentForRoyalty
3000000
CY2013 cers Expiration Of Non Cancelable Operating Leases Maximum Year
ExpirationOfNonCancelableOperatingLeasesMaximumYear
2019
CY2013 cers Inventory Life Finished Goods Period
InventoryLifeFinishedGoodsPeriod
P2Y
CY2013 cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
15000000
CY2013 cers Purchase Commitment Payments
PurchaseCommitmentPayments
6500000
CY2013 cers Issuance Of Common Stock From Exercise Of Stock Options Or Warrants And Purchases From Employee Stock Purchase Plans Value
IssuanceOfCommonStockFromExerciseOfStockOptionsOrWarrantsAndPurchasesFromEmployeeStockPurchasePlansValue
2296000
CY2013 cers Work In Process Inventory Life Period
WorkInProcessInventoryLifePeriod
P1Y
CY2013 cers Eligible To Receive Royalty Fee
EligibleToReceiveRoyaltyFee
0.01 pure
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.78
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
30.44
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
386000 shares
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55061000 shares
CY2012 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
546000 shares
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.68
CY2012 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
-800000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.13
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13917000
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
156000 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
98000 shares
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8716000 shares
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.30
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1782000 shares
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54515000 shares
CY2012 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-2059000
CY2012 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
13821000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-16360000
CY2012 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
900000
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
162000
CY2012 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1663000
CY2012 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1000
CY2012 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
36695000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
685000
CY2012 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
920000
CY2012 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
31000
CY2012 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-17976000
CY2012 us-gaap Interest Paid
InterestPaid
460000
CY2012 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
550000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-15675000
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1652000
CY2012 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
86000
CY2012 us-gaap Revenues
Revenues
36786000
CY2012 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
537000
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15917000
CY2012 us-gaap Gross Profit
GrossProfit
16079000
CY2012 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0
CY2012 us-gaap Revenue From Grants
RevenueFromGrants
91000
CY2012 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-20000
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-17300000
CY2012 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
81000
CY2012 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
0
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1625000
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-15917000
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3740000
CY2012 us-gaap Dilutive Securities
DilutiveSecurities
-2059000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2541000
CY2012 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2012 us-gaap Inventory Write Down
InventoryWriteDown
1700000
CY2012 us-gaap Cost Of Goods Sold
CostOfGoodsSold
20616000
CY2012 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
9496000
CY2012 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
62000
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14911000
CY2012 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
600000
CY2012 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1761000
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
2541000
CY2012 us-gaap Depreciation And Amortization
DepreciationAndAmortization
400000
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1199000
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
99000
CY2012 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2012 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
287000
CY2012 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2012 us-gaap Operating Expenses
OperatingExpenses
33470000
CY2012 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
19000
CY2012 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25665000
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
242000
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-34000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
300000
CY2012 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1971000
CY2012 us-gaap Interest Expense
InterestExpense
551000
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense Amortization
IncomeTaxReconciliationNondeductibleExpenseAmortization
48000
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2506000
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14226000
CY2012 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-5329000
CY2012 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
48000
CY2012 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
7603000
CY2012 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2012 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1810000
CY2012 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
14000
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
744000
CY2012 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
202000
CY2012 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
180000
CY2012 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
180000
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2541000
CY2012 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
CY2012 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
17000
CY2012 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-53000
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
205000
CY2012 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2012 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2012 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
332000
CY2012 cers Warrant Liability Revaluation Gain Loss
WarrantLiabilityRevaluationGainLoss
2059000
CY2012 cers Income Tax Reconciliation Nondeductible Expense Lobbying Expenses
IncomeTaxReconciliationNondeductibleExpenseLobbyingExpenses
51000
CY2012 cers Payment For Royalty
PaymentForRoyalty
2700000
CY2012 cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
12200000
CY2012 cers Income Tax Reconciliation Change In Fair Value Of Warrants
IncomeTaxReconciliationChangeInFairValueOfWarrants
-706000
CY2012 cers Income Tax Reconciliation Expiration Of Federal Net Operating Losses
IncomeTaxReconciliationExpirationOfFederalNetOperatingLosses
-4352000
CY2012 cers Purchase Commitment Payments
PurchaseCommitmentPayments
7200000
CY2012 cers Issuance Of Common Stock From Exercise Of Stock Options Or Warrants And Purchases From Employee Stock Purchase Plans Value
IssuanceOfCommonStockFromExerciseOfStockOptionsOrWarrantsAndPurchasesFromEmployeeStockPurchasePlansValue
349000
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
9733000
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10201000
CY2013Q1 us-gaap Gross Profit
GrossProfit
4643000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4960000
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5241000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-10252000
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5090000
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
9603000
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6853000
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51000
CY2013Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
2700000
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
50000
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2012Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
8691000
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8799000
CY2012Q1 us-gaap Gross Profit
GrossProfit
3177000
CY2012Q1 us-gaap Revenue From Grants
RevenueFromGrants
91000
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4572000
CY2012Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4227000
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-8834000
CY2012Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5514000
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
7840000
CY2012Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5966000
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
35000
CY2012Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1824000
CY2012Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
50000
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
9224000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1866000
CY2012Q2 us-gaap Gross Profit
GrossProfit
3650000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4799000
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2933000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-1907000
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5574000
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
8449000
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6686000
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41000
CY2012Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1712000
CY2012Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
51000
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
10150000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6670000
CY2013Q2 us-gaap Gross Profit
GrossProfit
4403000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7108000
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
438000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-6724000
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5747000
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
11511000
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7954000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54000
CY2013Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
3506000
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
51000
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
8252000
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3405000
CY2012Q3 us-gaap Gross Profit
GrossProfit
3841000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4331000
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
926000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-3460000
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
10542000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-20441000
CY2013Q3 us-gaap Gross Profit
GrossProfit
3716000
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
4411000
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
8172000
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6219000
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55000
CY2012Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1903000
CY2012Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
50000
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8425000
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12016000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-20501000
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
6826000
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
12141000
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7728000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
60000
CY2013Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
4363000
CY2013Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
50000
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2012Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2012Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
10528000
CY2012Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1605000
CY2012Q4 us-gaap Gross Profit
GrossProfit
5411000
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-3598000
CY2012Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1993000
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-1716000
CY2012Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5117000
CY2012Q4 us-gaap Operating Expenses
OperatingExpenses
9009000
CY2012Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6794000
CY2012Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
111000
CY2012Q4 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
2164000
CY2012Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
51000
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2013Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
9232000
CY2013Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5807000
CY2013Q4 us-gaap Gross Profit
GrossProfit
4293000
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-7806000
CY2013Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1999000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-5860000
CY2013Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
4939000
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
12099000
CY2013Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7430000
CY2013Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
53000
CY2013Q4 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
4618000
CY2013Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
51000

Files In Submission

Name View Source Status
0001193125-14-089394-index-headers.html Edgar Link pending
0001193125-14-089394-index.html Edgar Link pending
0001193125-14-089394.txt Edgar Link pending
0001193125-14-089394-xbrl.zip Edgar Link pending
cers-20131231.xml Edgar Link completed
cers-20131231.xsd Edgar Link pending
cers-20131231_cal.xml Edgar Link unprocessable
cers-20131231_def.xml Edgar Link unprocessable
cers-20131231_lab.xml Edgar Link unprocessable
cers-20131231_pre.xml Edgar Link unprocessable
d617529d10k.htm Edgar Link pending
d617529dex1015.htm Edgar Link pending
d617529dex1018.htm Edgar Link pending
d617529dex1028.htm Edgar Link pending
d617529dex104.htm Edgar Link pending
d617529dex1048.htm Edgar Link pending
d617529dex105.htm Edgar Link pending
d617529dex121.htm Edgar Link pending
d617529dex211.htm Edgar Link pending
d617529dex231.htm Edgar Link pending
d617529dex311.htm Edgar Link pending
d617529dex312.htm Edgar Link pending
d617529dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g617529g36z46.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending